Home Metabolism Carbohydrate Metabolism modulator - Apoptosis related activator - HSV inhibitor 2-DG (2-Deoxy-D-glucose) For research use only.

2-DG (2-Deoxy-D-glucose)

Synonyms: 2-deoxyglucose, NSC 15193, 2-Deoxy-D-arabino-hexose, D-Arabino-2-deoxyhexose

2-DG (2-Deoxy-D-glucose), an analog of glucose, is a glycolytic inhibitor with antiviral activity. 2-Deoxy-D-glucose induces apoptosis and inhibits Herpes Simplex Virus type-1 (HSV-1) receptor expression.

2-DG (2-Deoxy-D-glucose) Chemical Structure

2-DG (2-Deoxy-D-glucose) Chemical Structure

CAS: 154-17-6

Selleck's 2-DG (2-Deoxy-D-glucose) has been cited by 57 publications

Purity & Quality Control

Batch: Purity: >97%
97

Products often used together with 2-DG (2-Deoxy-D-glucose)

Albendazole

2-Deoxy-D-glucose and Albendazole combination use exhibits high efficiency in treating human echinococcosis.

Xin Q, et al. PLoS Negl Trop Dis. 2022 Jul 18;16(7):e0010618.

Fenofibrate

2-Deoxy-D-glucose and Fenofibrate induce necrotic and apoptotic cell death in different tumor cell lines.

Liu H, et al. Oncotarget. 2016 Jun 14;7(24):36461-36473.

Venetoclax (ABT-199)

2-Deoxy-D-glucose and Venetoclax induce apoptosis in multiple myeloma cell lines.

Halliez M, et al. Blood (2013) 122 (21): 1921.

Metformin

2-Deoxy-D-glucose and Metformin enhance tumor cell ablation upon Cobalt60 radiation treatment in breast cancer cell lines.

Chatterjee S, et al. Breast Cancer (Dove Med Press). 2015 Aug 31;7:251-65.

Doxorubicin

2-DG and Doxorubicin lower glutathione, increase oxidation, lipid peroxidation, and cytotoxicity in T47D breast cancer cells.

Mustafa EH, et al. Asian Pac J Cancer Prev. 2015;16(8):3213-3222.

2-DG (2-Deoxy-D-glucose) Related Products

Choose Selective Carbohydrate Metabolism Inhibitors

Biological Activity

Description 2-DG (2-Deoxy-D-glucose), an analog of glucose, is a glycolytic inhibitor with antiviral activity. 2-Deoxy-D-glucose induces apoptosis and inhibits Herpes Simplex Virus type-1 (HSV-1) receptor expression.
Targets
glycolysis [1]
In vitro
In vitro 2-Deoxy-D-glucose(2-DG) activates AKT function through phosphatidylinositol 3-kinase (PI3K) and is independent of glycolysis or mTOR inhibition. 2-DG treatments disrupts the binding between insulin-like growth factor 1 (IGF-1) and IGF-binding protein 3 (IGFBP3) so that the free form of IGF-1 could be released from the IGF-1·IGFBP3 complex to activate IGF-1 receptor (IGF1R) signaling. 2-DG-induced activation of many survival pathways can be jointly attenuated through IGF1R inhibition. 2-DG also induces time- and dose-dependent ERK phosphorylation[1]. 2-DG is readily transported into cells and is phosphorylated by hexokinase, but cannot be metabolized further and accumulates in the cell. This leads to ATP depletion and the induction of cell-death[2]. 2DG significantly suppresses proliferation, causes apoptosis and reduces migration of murine endothelial cells, inhibiting formation of lamellipodia and filopodia and causing disorganization of F-actin filaments in murine endothelial cell[5].
Cell Research Cell lines H460 or H157 cells
Concentrations 5 mM
Incubation Time 48 h
Method

2×103 H460 or H157 cells are seeded in 96-well cell culture plates. Cells are treated with 5 mM 2-DG only, 5 or 10 μM IGF1R inhibitor II only, or a combination of 2-DG and IGF1R inhibitor II. Cell growth inhibition is determined after 48 h by the CellTiter 96® AQueous nonradioactive cell proliferation assay.
In Vivo
In vivo Treatment of cancer patients with relatively high doses of 2-DG (greater than 200 mg/kg) was largely ineffective in managing tumor growth. Side effects of 2-DG included elevated blood glucose levels, progressive weight loss with lethargy, and behavioral symptoms of hypoglycemia[2]. 2-DG enhances isoflurane-induced loss of righting reflex in mice. By reducing metabolism, 2-DG treatment can decrease body temperature in rodent, enhancing sensitivity to anesthetics[3]. 2-DG diet significantly increased serum ketone body level and brain expression of enzymes required for ketone body metabolism. The 2-DG-induced maintenance of mitochondrial bioenergetics was paralleled by simultaneous reduction in oxidative stress. Further, 2-DG treated mice exhibited a significant reduction of both amyloid precursor protein (APP) and amyloid beta (Aβ) oligomers, which was paralleled by significantly increased α-secretase and decreased γ-secretase expression, indicating that 2-DG induced a shift towards a non-amyloidogenic pathway. 2-DG increased expression of genes involved in Aβ clearance pathways, degradation, sequestering, and transport. Concomitant with increased bioenergetic capacity and reduced β-amyloid burden, 2-DG significantly increased expression of neurotrophic growth factors, BDNF and NGF, thus reduces pathology in female mouse model of Alzheimer's disease[4].
Animal Research Animal Models Adult C57BL/6J mice
Dosages 1000 mg/kg
Administration i.p.
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02558140 Completed
Neoplasms
Hoffmann-La Roche
 October 11 2015 Phase 1
NCT01998841 Completed
Alzheimer''s Disease
Genentech Inc.|Banner Alzheimer''s Institute|National Institute on Aging (NIA)
 December 20 2013 Phase 2

Chemical Information & Solubility

Molecular Weight 164.16 Formula

C6H12O5
CAS No. 154-17-6 SDF Download 2-DG (2-Deoxy-D-glucose) SDF
Smiles C(C=O)C(C(C(CO)O)O)O
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 33 mg/mL ( (201.02 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : 33 mg/mL

Ethanol : 5.5 mg/mL


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy 2-DG (2-Deoxy-D-glucose) | 2-DG (2-Deoxy-D-glucose) supplier | purchase 2-DG (2-Deoxy-D-glucose) | 2-DG (2-Deoxy-D-glucose) cost | 2-DG (2-Deoxy-D-glucose) manufacturer | order 2-DG (2-Deoxy-D-glucose) | 2-DG (2-Deoxy-D-glucose) distributor